InvestorsHub Logo
Followers 827
Posts 119480
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Tuesday, 07/25/2017 4:35:49 PM

Tuesday, July 25, 2017 4:35:49 PM

Post# of 634
EXAS +8%/AH on 2Q17 results (135K tests) and raised full-year guidance (470K—>550K tests):

http://investor.exactsciences.com/investor-relations/press-releases/press-release-details/2017/Cologuard-revenue-increased-to-576-million-during-second-quarter-Test-volume-grew-149-percent-from-second-quarter-of-2016-to-135000-completed-tests/default.aspx

It was pretty clear that the old (470k-test) 2017 guidance was lowballed inasmuch as it would’ve represented very slow growth from the 100K tests performed during 1Q17.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EXAS News